[go: up one dir, main page]

GB2443377A - Anti-malarial composition comprising artesunate and lumefantrine - Google Patents

Anti-malarial composition comprising artesunate and lumefantrine

Info

Publication number
GB2443377A
GB2443377A GB0804039A GB0804039A GB2443377A GB 2443377 A GB2443377 A GB 2443377A GB 0804039 A GB0804039 A GB 0804039A GB 0804039 A GB0804039 A GB 0804039A GB 2443377 A GB2443377 A GB 2443377A
Authority
GB
United Kingdom
Prior art keywords
lumefantrine
artesunate
composition
malarial composition
malarial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB0804039A
Other versions
GB0804039D0 (en
Inventor
Amar Lulla
Geena Malhotra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cipla Ltd
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of GB0804039D0 publication Critical patent/GB0804039D0/en
Publication of GB2443377A publication Critical patent/GB2443377A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A pharmaceutical composition comprising artesunate and lumefantrine provided in combination in a single pharmaceutical dosage unit. The invention also relates to a method of making the pharmaceutical composition, and to the use of the composition in the treatment of malaria.
GB0804039A 2005-08-05 2008-03-04 Anti-malarial composition comprising artesunate and lumefantrine Withdrawn GB2443377A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN794MU2005 2005-08-05
PCT/GB2006/002919 WO2007017646A2 (en) 2005-08-05 2006-08-04 Anti-malarial composition comprising artesunate and lumefantrine

Publications (2)

Publication Number Publication Date
GB0804039D0 GB0804039D0 (en) 2008-04-09
GB2443377A true GB2443377A (en) 2008-04-30

Family

ID=37649482

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0804039A Withdrawn GB2443377A (en) 2005-08-05 2008-03-04 Anti-malarial composition comprising artesunate and lumefantrine

Country Status (3)

Country Link
GB (1) GB2443377A (en)
WO (1) WO2007017646A2 (en)
ZA (1) ZA200801208B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH696229A5 (en) * 2006-05-13 2007-02-28 Professeur Dr Achille Benakis New galenic forms of Artemisinin and its derivatives in combination with other antimalarials for the treatment of malaria.
FR2914860B1 (en) * 2007-04-12 2009-05-22 Ile D Inventeurs Apis Spheromo MULTILAYER SPHEROIDS WITH ANTIPALUDITIC ACTION IN WHICH ONE OF THE LAYERS CONTAINS ARTESUNATE
WO2010004573A1 (en) * 2008-07-07 2010-01-14 Ipca Laboratories Limited Synergistic antimalarial pharmaceutical composition
WO2011009956A1 (en) * 2009-07-24 2011-01-27 Dafra Pharma N.V. Injectable aqueous solution containing artesunate

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992002217A1 (en) * 1990-08-08 1992-02-20 Ciba-Geigy Ag Antimalarial compositions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992002217A1 (en) * 1990-08-08 1992-02-20 Ciba-Geigy Ag Antimalarial compositions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Independent Review of Medicines for malaria venture" DFID Helath Resource Centre, {Online], 31 May 2005, pp.1-28, London, UK. Retrieved from the internet; URL: <http://www.mmv.org/IMG/pdf/MMV_Final_Report_7.7.05.pdf> *
RATIONAL PHARMACEUTICAL MANAGMENT PLUS, [Online], 31 May 2005, KABUYA-MUTSHIPAYI, pp.1-11. Retrieved from the internet: URL<:http://pdf.dec.org/pdf_docs/PDACF086.pdf> *

Also Published As

Publication number Publication date
WO2007017646A2 (en) 2007-02-15
WO2007017646A3 (en) 2007-04-19
ZA200801208B (en) 2009-05-27
GB0804039D0 (en) 2008-04-09

Similar Documents

Publication Publication Date Title
IL191984A0 (en) Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents for the treatment of cancer
IL189914A0 (en) Substituted 4-phenyltetrahydroisoquinolines, method of producing them, their use as medicament, and also medicament containing them
IL184424A0 (en) Cxcr4 antagonists for the treatment of hiv infection
IL181171A0 (en) 17-desmethylrapamycin and analogues thereof, methods for their production and their use as immunosupressants, anticancer agents, antifungal agents, etc
EP1581188A4 (en) Pharmaceutical safety dosage forms
IL184051A (en) Acylated glp-1 compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
MX2007008790A (en) Substituted pyrazolo-pyridines, compositions containing them, method for the production thereof, and their use.
IL180872A0 (en) Substituted 8-aminoalkylthio-xanthines, and the use thereof as inhibitors of the dipeptidyl peptidase iv
IL185484A0 (en) Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents
ZA200608029B (en) Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
JO2721B1 (en) Artemisinin Derivative Dimers, Their preparation and their therapeutic application
EP1783137A4 (en) Galactose derivative, drug carrier and medicinal composition
UA97401C2 (en) Improved taste-masking extrudates
GB2443377A (en) Anti-malarial composition comprising artesunate and lumefantrine
SI1807156T1 (en) New pharmaceutical formulations useful in the treatment of insomnia
ZA200710146B (en) New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
GEP20115158B (en) Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunction
IL186851A0 (en) Styrylsulfonamides, their manufacture and use as pharmaceutical agents
WO2008001294A3 (en) High dose oral pharmaceutical compositions of artemether and lumefantrine
ZA200701578B (en) Combination anticancer therapy and pharmaceutical compositions therefore
MY142082A (en) Substituted pyrroles, compositions containing them, method of manufacture and use
IL190675A0 (en) Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents
IL182835A0 (en) Process for and imtermediates in the preparaition of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents
IL187419A0 (en) Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents
IL179697A0 (en) Variants of unc5h2, their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)